Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?

This publication has 19 references indexed in Scilit:

• High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample
  Journal of Chromatography B: Biomedical Sciences and Applications, 1992
• Inhibition of first-pass metabolism in cancer chemotherapy: Interaction of 6-mercaptopurine and allopurinol
  Clinical Pharmacology & Therapeutics, 1983
• Childhood leukaemia: a relationship between intracellular 6‐ mercaptopurine metabolites and neutropenia.
  British Journal of Clinical Pharmacology, 1983
• 6-Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia
  British Journal of Cancer, 1982
• Phase II evaluation and plasma pharmacokinetics of high-dose intravenous 6-thioguanine in patients with colorectal carcinoma
  Cancer Chemotherapy and Pharmacology, 1982
• Clinical pharmacology of oral thioguanine in acute myelogenous leukemia
  Cancer Chemotherapy and Pharmacology, 1981
• MERCAPTOPURINE PHARMACOGENETICS - MONOGENIC INHERITANCE OF ERYTHROCYTE THIOPURINE METHYLTRANSFERASE ACTIVITY
  1980
• A reliable method for evaluating drug compliance in children with cancer
  Cancer, 1979
• Portal hypertension in a patient with chronic myeloid leukaemia
  Published by Oxford University Press (OUP) ,1977
• CLINICAL AND PHARMACOLOGIC EFFECTS OF COMBINATIONS OF 6-THIOGUANINE AND DUAZOMYCIN A IN PATIENTS WITH NEOPLASTIC DISEASE
  1965